The invention relates to a composition comprising at least one anionic surfactant, a betaine surfactant, a mixture of N-methyl-N-acylglucamines, a glycerol derivative, a solvent, and optionally one or more additives, and to a method for preparing the composition. The invention relates further to the use of the composition for the treatment or care of the skin or hair, for example as a shampoo, facial cleanser, liquid cleanser or shower gel.
In the preparation of compositions, in particular the preparation of cleansing compositions, a number of criteria are to be observed, such as, for example, a good cleansing action, adequate foaming properties, good skin tolerability, a good feel in relation to the skin, hair and especially no irritation of the mucosa. Skin and hair consist of a plurality of layers which comprise inter alia keratin and collagen as fiber proteins. Anionic surfactants can penetrate the layers and damage them. Ideal cleansing agents for cosmetic or pharmaceutical applications should gently clean the skin or the hair without removing oil from and/or drying the hair and the skin and without causing irritation. Most foaming soaps, shower and bath additives, shampoos and cosmetics fail in this regard or exhibit correspondingly poor foaming behavior.
EP 0 550 637 A1 describes a process for preparing polyhydroxy fatty acid amide materials which can be used inter alia as surfactants. The process is particularly useful when the N-alkylpolyhydroxyamine has the formula N(R1)CH2(CH2OH)4CH2OH. A C12-C20-fatty acid methyl ester is preferably used in the process. A preferred process for preparing detergent surfactants is one in which the N-alkylpolyhydroxyamine is an N-methylglucoamine, the fatty acid ester is a C12-C20-methyl ester or a mixture thereof, the solvent is methanol, and the catalyst is sodium methoxide.
Document WO 92/06158 relates to a low-foam detergent composition comprising at least 1% by weight of a polyhydroxy fatty acid amide surfactant of the formula
wherein R1 is H, C1-C4-hydrocarbon, 2-hydroxyethyl or 2-hydroxypropyl, R2 is C5-C31-hydrocarbon, and Z is a polyhydroxy hydrocarbon having a linear hydrocarbon chain with at least three hydroxyl groups bonded directly to the chain, or alkoxylated derivatives thereof; at least 1% of an alkylalkoxylated sulfate surfactant; and optionally a foam-suppressing amount of a foam suppressor which is chosen from monocarboxylic fatty acids and salts thereof, silicone foam suppressors and monostearyl kiakali metal phosphates or phosphate esters, and high molecular weight hydrocarbon foam suppressors and mixtures thereof; wherein the composition has an alkylalkoxylated sulfate:polyhydroxy fatty acid amide weight ratio of from 10:1 to 1:10, preferably from 5:1 to 1:5 and more preferably from 4:1 to 1:1 and the polyhydroxy fatty acid amide comprises less than 4% by weight of a cyclic amide secondary product.
WO 98/56496 relates to a surfactant composition having improved foam stability. The surfactant composition comprises: (a) from approximately 1 to approximately 40% by weight of a sugar-based surfactant; (b) from approximately 1 to approximately 40% by weight of an anionic surfactant; (c) from approximately 0.11 to approximately 10% by weight of an amphoacetate; and (d) remainder water, wherein the amounts by weight are based on the weight of the composition.
Accordingly, the object of the invention is to provide improved compositions, in particular with regard to improved foam behavior.
Surprisingly, it has been found that formulations comprising N-acyl-N-methylglucamines having a chain distribution of natural coconut oil or palm kernel oil are superior in terms of the foam properties to the C12/14 N-acyl-N-methylglucamines mentioned in WO 92/06158. N-Acyl-N-methylglucamines that have been prepared from triglyceride oil and accordingly comprise glycerol and small amounts of glycerol derivatives exhibit particular advantages.
There is accordingly provided a composition comprising:
The composition according to the invention is distinguished in particular by a synergistic action of components C and D. As is apparent from the comparative example, a composition without component D does not lead to the same effect as the composition according to the invention. This can be attributed to the fact that the products formed in the reaction of a triglyceride and an N-methylglucamine, in particular in their specific ratio, surprisingly lead to the improved properties.
The anionic surfactant of component A can be, for example, an amino acid surfactant. Preference is given to acyl glycinates, acyl alaninates, acyl aspartates, acyl glutamates and acyl sarcosinates, in particular sodium cocoyl glycinate, potassium cocoyl glycinate, sodium lauroyl glycinate, potassium lauroyl glycinate, sodium cocoyl glutamate, sodium lauroyl glutamate, sodium cocoyl aspartate, sodium lauroyl aspartate and sodium lauroyl sarcosinate.
In a preferred embodiment, component A is selected from one or more compound(s) of formula (I)
R1SO3−M+ (I)
wherein R1 represents alkyl, cycloalkyl, aralkyl, aryl, alkoxy, alkoxyalkyl or heterocyclyl and M+ is an alkali metal, alkaline earth metal or substituted or unsubstituted ammonium ion,
and/or of formula (II)
R1SO4−M+ (II)
wherein R1 represents alkyl, cycloalkyl, aralkyl, aryl, alkoxy, alkoxyalkyl and heterocyclyl and M+ is an alkali metal, alkaline earth metal or substituted or unsubstituted ammonium ion.
“Alkyl” denotes a saturated aliphatic hydrocarbon group which can be straight-chained or branched and can have from 1 to 20 carbon atoms in the chain. Preferred alkyl groups can be straight-chained or branched and have from 1 to 10 carbon atoms in the chain. Branched means that a lower alkyl group, such as methyl, ethyl or propyl, is attached to a linear alkyl chain. Alkyl is, for example, methyl, ethyl, 1-propyl, 2-propyl, 1-butyl, 2-butyl, 2-methyl-1-propyl (isobutyl), 2-methyl-2-propyl (tert-butyl), 1-pentyl, 2-pentyl, 3-pentyl, 2-methyl-1-butyl, 3-methyl-1-butyl, 2-methyl-2-butyl, 3-methyl-2-butyl, 2,2-dimethyl-1-propyl, 1-hexyl, 2-hexyl, 3-hexyl, 2-methyl-1-pentyl, 3-methyl-1-pentyl, 4-methyl-1-pentyl, 2-methyl-2-pentyl, 3-methyl-2-pentyl, 4-methyl-2-pentyl, 2-methyl-3-pentyl, 3-methyl-3-pentyl, 2,2-dimethyl-1-butyl, 2,3-dimethyl-1-butyl, 3,3-dimethyl-1-butyl, 2-ethyl-1-butyl, 2,3-dimethyl-2-butyl, 3,3-dimethyl-2-butyl, 1-heptyl, 1-octyl, 1-nonyl, 1-decyl, 1-undecyl, 1-dodecyl, 1-tetradecyl, 1-hexadecyl and 1-octadecyl.
“Cycloalkyl” denotes an aliphatic ring which has from 3 to 10 carbon atoms in the ring. Preferred cycloalkyl groups have from 4 to 7 carbon atoms in the ring.
“Aryl” denotes phenyl or naphthyl.
“Aralkyl” denotes an alkyl group which is substituted by an aryl radical.
“Substituted aralkyl” and “substituted aryl” mean that the aryl group or the alkyl group of the aralkyl group is substituted by one or more substituents selected from alkyl, alkoxy, nitro, carboalkoxy, cyano, halo, alkylmercaptyl, trihaloalkyl or carboxyalkyl.
“Alkoxy” denotes an alkyl-0 group in which “alkyl” has the meaning described above. Lower alkoxy groups are preferred. Examples are methoxy, ethoxy, n-propoxy, isopropoxy and n-butoxy.
“Lower alkyl” denotes an alkyl group which has from 1 to 7 carbon atoms.
“Alkoxyalkyl” denotes an alkyl group as described above which is substituted by an alkoxy group as described above. Accordingly, the term alkoxyalkyl can be understood as including a polyether.
“Heterocyclyl” denotes a 4- to 10-membered ring structure in which one or more ring atoms are other than carbon, for example N, O or S. Heterocyclyl can be aromatic or non-aromatic, that is to say it can be saturated, partially saturated or completely unsaturated.
Particularly preferred as component A are sodium lauryl sulfate and/or sodium lauryl ether sulfate.
Component B is selected from the group consisting of at least one alkyl betaine, alkylamido betaine or mixtures thereof.
Examples of suitable alkyl betaines are the carboxyalkylation products of secondary and in particular tertiary amines of formula (III)
wherein R2 represents alkyl and/or alkenyl radicals having from 6 to 22 carbon atoms, R3 represents hydrogen or alkyl radicals having from 1 to 4 carbon atoms, R4 represents hydrogen or alkyl radicals having from 1 to 4 carbon atoms, n represents numbers from 1 to 6, and Z represents an alkali and/or alkaline earth metal or ammonium. Typical examples are the carboxymethylation products of hexylmethylamine, hexyldimethylamine, octyldimethylamine, decyldimethylamine, dodecylmethylamine, dodecyl-dimethylamine, dodecylethylmethylamine, C12/14-coco alkyldimethyl-amine, myristyldimethylamine, cetyldimethylamine, stearyldimethylamine, stearylethylmethylamine, oleyldimethylamine, C16/18-tallow alkyldimethyl-amine and commercial mixtures thereof.
Examples of suitable alkylamido betaines are carboxyalkylation products of amidoamines. Particularly suitable are amidopropyl betaines of formula (IV)
wherein R5 is a linear or branched saturated C7-C21-alkyl group or a linear or branched mono- or poly-unsaturated C7-C21-alkenyl group.
Preferred betaine surfactants are amidopropyl betaines such as cocoamidopropyl betaine (R5CO is the fatty acid radical of coconut oil, chain length C8-C18) and alkyl betaines such as coco-betaine (R2 is the alkyl radical of coconut oil, chain length C8-C18) or lauryl betaine (R2 is an alkyl radical of chain length C12 and C14).
For example and preferably, the N-methyl-N-acylglucamine mixture (C) can be prepared according to EP 0 550 637 from the corresponding triglycerides and N-methylglucamine in the presence of 1,2-propylene glycol as solvent. In a preferred embodiment, components (C) and (D) are formed by transamidation of the triglycerides coconut oil and/or palm kernel oil with N-methylglucamine.
Further terms for N-methyl-N-acylglucamine are N-methyl-N-1-deoxysorbitol fatty acid amide, N-acyl-N-methyl-glucamine, glucamide or N-methyl-N-alkylglucamide. N-Methyl-N-acylglucamine corresponds to formula (V), wherein R is an organic radical:
According to the invention, R—CO corresponds to the C8-C22-acyl radicals of natural coconut oil and/or palm kernel oil.
In a preferred embodiment, the distribution of the C8-C22-acyl radicals in the N-methyl-N-acylglucamine mixture corresponds to that of natural coconut oil.
The distribution of the C8-C22-acyl radicals which corresponds to that of natural coconut oil corresponds to the C8-C22-fatty acids in coconut oil.
Coconut oil comprises triglycerides.
Coconut oil comprises
a) from 40 to 55% by weight lauric acid,
b) from 10 to 20% by weight myristic acid,
c) from 8 to 12% by weight palmitic acid,
d) from 6 to 12% by weight oleic acid, and
h) from 0 to 36% by weight further fatty acids,
wherein the sum of the fatty acids bonded to the triglyceride is 100% by weight.
Particularly preferably, coconut oil comprises
a) from 40 to 55% by weight lauric acid,
b) from 10 to 20% by weight myristic acid,
c) from 8 to 12% by weight palmitic acid,
d) from 6 to 12% by weight oleic acid,
e) from 5 to 10% by weight decanoic acid,
f) from 4 to 10% by weight octanoic acid,
g) from 1 to 3% by weight stearic acid, and
h) from 0 to 26% by weight further fatty acids,
wherein the sum of the fatty acids bonded to the triglyceride is 100% by weight.
In a further preferred embodiment, the distribution of the C8-C22-acyl radicals in the N-methyl-N-acylglucamine mixture corresponds to that of natural palm kernel oil.
The distribution of the C8-C22-acyl radicals which corresponds to that of natural palm kernel oil corresponds to the C8-C22-fatty acids in palm kernel oil. Palm kernel oil comprises triglycerides.
Palm kernel oil comprises
a) from 45 to 55% by weight lauric acid,
b) from 14 to 18% by weight myristic acid,
c) from 6 to 10% by weight palmitic acid,
d) from 10 to 17% by weight oleic acid, and
h) from 0 to 25% by weight further fatty acids,
wherein the sum of the fatty acids bonded to the triglyceride is 100% by weight.
Particularly preferably, palm kernel oil comprises
a) from 46 to 49% by weight lauric acid,
b) from 15 to 17% by weight myristic acid,
c) from 7 to 9% by weight palmitic acid,
d) from 13 to 15% by weight oleic acid,
e) from 1 to 3% by weight decanoic acid,
f) from 1 to 3% by weight octanoic acid,
g) from 2 to 4% by weight stearic acid, and
h) from 0 to 15% by weight further fatty acids,
wherein the sum of the fatty acids bonded to the triglyceride is 100% by weight.
In a further preferred embodiment, the distribution of the C8-C22-acyl radicals in the N-methyl-N-acylglucamine mixture corresponds to that of a mixture of natural coconut oil and palm kernel oil.
There are used as glycerol derivatives D preferably those formed in the transamidation of coconut oil and/or palm kernel oil with N-methylglucamine. Examples of further glycerol derivatives which come into consideration are triglycerides of linear or branched, saturated or unsaturated, optionally hydroxylated C8-C30-fatty acids, in particular vegetable oils, such as sunflower oil, corn oil, soybean oil, rice oil, jojoba oil, babusscu oil, pumpkin oil, grapeseed oil, sesame oil, walnut oil, apricot oil, orange oil, wheatgerm oil, peach kernel oil, macadamia oil, avocado oil, sweet almond oil, meadow foam seed oil, castor oil, olive oil, groundnut oil, rapeseed oil and coconut oil, as well as synthetic triglyceride oils. Hardened triglycerides are also preferred according to the invention. Oils of animal origin, for example beef tallow, perhydrosqualene and lanolin, can also be used. In addition to the triglycerides, mono- and di-glycerides can also be used.
A solvent E within the scope of the present invention is preferably understood as being protic solvents such as water, C1-C8-alcohols, in particular C1-C6-alcohols, ethylene glycol, diethylene glycol, triethylene glycol or mixtures thereof, particular preference being given to water and/or ethanol or water and/or methanol. Of the C1-C6-alcohols, methanol, ethanol, isopropanol, n-butanol or sec-butanol are preferred.
The preferred solvent is water or mixtures of water and propylene glycol.
Within the scope of a preferred embodiment, the additives F—where present—are chosen from the group consisting of preservatives, fragrances, dyes, surfactants, water, oily substances, cationic polymers, film-forming agents, thickeners and gelling agents, superfatting agents, antimicrobial and biogenic active ingredients, moisture-donating substances, stabilizers, acids, lyes, activity enhancers and mixtures thereof, preferably in amounts of from 0.1 to 10.0% by weight, particularly preferably from 0.5 to 8.0% by weight, and in particular from 1.0 to 5.0% by weight.
Suitable preservatives are the preservatives listed in the relevant annex to the European cosmetic products legislation, for example phenoxyethanol, benzyl alcohol, parabens, benzoic acid and sorbic acid, particularly suitable are, for example, 1,3-bis(hydroxymethyl)-5,5-dimethylimidazolidine-2,4-dione (Nipaguard® DMDMH), piroctone olamine, methylisothiazolinone or mixtures thereof, preferably piroctone, olamine and/or methylisothiazolinone.
As fragrances or perfumes or oils there can be used individual fragrance compounds, for example the synthetic products of the ester, ether, aldehyde, ketone, alcohol and hydrocarbon type. Examples of fragrance compounds of the ester type are benzyl acetate, phenoxyethyl isobutyrate, p-tert-butylcyclohexyl acetate, linalyl acetate, dimethylbenzylcarbinyl acetate, phenylethyl acetate, linalyl benzoate, benzyl formate, ethylmethylphenyl glycinate, allylcyclohexyl propionate, styrallyl propionate and benzyl salicylate. The ethers include, for example, benzyl ethyl ether; the aldehydes include, for example, linear alkanals having from 8 to 18 carbon atoms, citral, citronellal, citronellyloxy acetaldehyde, cyclamen aldehyde, hydroxycitronellal, lilial and bourgeonal; the ketones include, for example, ionones, alpha-isomethylionone and methyl cedryl ketone; the alcohols include anethol, citronellol, eugenol, geranion, linalool, phenylethyl alcohol and terpineol; the hydrocarbons include mainly terpenes and balsams. Preference is given to the use of mixtures of different fragrances, which together produce a pleasant note.
Perfume oils can also comprise natural fragrance mixtures, as are obtainable from plant or animal sources, for example pine oil, citrus oil, jasmine oil, lily oil, rose oil or ylang-ylang oil. Ethereal oils of low volatility, which are mostly used as flavor components, are also suitable as perfume oils, for example salvia oil, chamomile oil, carnation oil, melissa oil, mint oil, cinnamon leaf oil, linden blossom oil, juniper berry oil, vetiver oil, olibanum oil, galbanum oil and ladanum oil.
The desired viscosity of the compositions can be adjusted (increased or lowered) by adding thickeners and gelling agents. There come into consideration preferably cellulose ethers and other cellulose derivatives (for example carboxymethylcellulose, hydroxyethylcellulose), gelatin, starch and starch derivatives, sodium alginates, fatty acid polyethylene glycol esters, agar-agar, tragacanth or dextrin derivatives, in particular dextrin esters. Also suitable are metal salts of fatty acids, preferably having from 12 to 22 carbon atoms, for example sodium stearate, sodium palmitate, sodium laurate, sodium arachidate, sodium behenate, potassium stearate, potassium palmitate, sodium myristate, aluminum monostearate, hydroxy fatty acids, for example 12-hydroxystearic acid, 16-hydroxyhexadecanoic acid; fatty acid amides; fatty acid alkanolamides; dibenzalsorbitol and alcohol-soluble polyamides and polyacrylamides or mixtures thereof. There can further be used crosslinked and uncrosslinked polyacrylates such as carbomers, sodium polyacrylates or sulfonic-acid-containing polymers such as ammonium acryloyldimethyltaurate/vinylpyrrolidone (VP) copolymer.
There are used as antimicrobial active ingredients, for example, cetyltrimethylammonium chloride, cetylpyridinium chloride, benzethonium chloride, diisobutylethoxyethyldimethylbenzylammonium chloride, sodium N-lauryl sarcosinate, sodium N-palmethyl sarcosinate, lauroyl sarcosine, N-myristoylglycine, potassium N-lauryl sarcosine, trimethylammonium chloride, sodium aluminum chlorohydroxylactate, triethyl citrate, tricetylmethylammonium chloride, 2,4,4′-trichloro-2′-hydroxydiphenyl ether (triclosan), phenoxyethanol, 1,5-pentanediol, 1,6-hexanediol, 3,4,4′-trichlorocarbanilide (triclocarban), diaminoalkylamide, for example L-lysine hexadecylamide, citrate heavy metal salts, salicylates, piroctose, in particular zinc salts, pyrithiones and heavy metal salts thereof, in particular zinc pyrithione, zinc phenolsulfate, farnesol, ketoconazole, oxiconazole, bifonazole, butoconazole, cloconazole, clotrimazole, econazole, enilconazole, fenticonazole, isoconazole, miconazole, sulconazole, tioconazole, fluconazole, itraconazole, terconazole, naftifine and terbinafine, selenium disulfide and octopirox, iodopropynyl butylcarbamate, methylchloroisothiazolinone, methylisothiazolinone, methyldibromo glutaronitrile, AgCl, chloroxylenol, sodium salt of diethylhexyl sulfosuccinate, sodium benzoate, as well as phenoxyethanol, benzyl alcohol, phenoxyisopropanol, parabens, preferably butyl-, ethyl-, methyl- and propyl-paraben, and sodium salts thereof, pentanediol, 1,2-octanediol, 2-bromo-2-nitropropane-1,3-diol, ethylhexylglycerol, benzyl alcohol, sorbic acid, benzoic acid, lactic acid, imidazolidinylurea, diazolidinylurea, dimethyloldimethylhydantoin (DMDMH), sodium salt of hydroxymethyl glycinate, hydroxyethylglycine of sorbic acid, and combinations of these active substances.
The compositions according to the invention can further comprise biogenic active ingredients selected from plant extracts, such as, for example, aloe vera, as well as local anesthetics, antibiotics, antiphlogistics, antiallergics, corticosteroids, sebostatic agents, Bisabolol®, Allantoin®, Phytantriol®, proteins, vitamins selected from niacin, biotin, vitamin B2, vitamin B3, vitamin B6, vitamin B3 derivatives (salts, acids, esters, amides, alcohols), vitamin C and vitamin C derivatives (salts, acids, esters, amides, alcohols), preferably as the sodium salt of the monophosphoric acid ester of ascorbic acid or as the magnesium salt of the phosphoric acid ester of ascorbic acid, tocopherol and tocopherol acetate, as well as vitamin E and/or derivatives thereof.
There can be used as stabilizers metal salts of fatty acids, such as, for example, magnesium stearate, aluminum stearate and/or zinc stearate.
There are available as the moisture-donating substance, for example, isopropyl palmitate, glycerol and/or sorbitol.
There can be used as superfatting agents preferably lanolin and lecithin, non-ethoxylated and polyethoxylated or acylated lanolin and lecithin derivatives, polyol fatty acid esters, mono-, di- and tri-glycerides and/or fatty acid alkanolamides, the latter at the same time acting as foam stabilizers, which are preferably used in amounts of from 0.01 to 10% by weight, particularly preferably from 0.1 to 5.0% by weight and most particularly preferably from 0.5 to 3.0% by weight.
As acids or lyes for adjusting the pH there are preferably used mineral acids, in particular HCl, inorganic bases, in particular NaOH or KOH, or organic acids, in particular citric acid.
Within the scope of a preferred embodiment, the composition comprises
Preferably, the composition consists of
Within the scope of a further preferred embodiment, the composition comprises
Within the scope of a particularly preferred embodiment, the composition comprises
Within the scope of a preferred embodiment, the sum of components A, B and C is from 7 to 20% by weight, preferably from 10 to 18% by weight and in particular from 10 to 15% by weight.
Preference is given to a ratio of component A:component B:component C of from 2:1:1 to 4:1:1. Particular preference is given to a ratio of 3:1:1.
Within the scope of a preferred embodiment, the composition is a cosmetic, dermatological or pharmaceutical composition.
The invention further provides the use of the composition according to the invention as a shampoo, facial cleanser, liquid cleanser or shower gel.
The invention further provides the use of the composition according to the invention for the treatment or care of the skin.
The invention further provides the use of the composition according to the invention for the treatment or care of the hair.
The invention further provides methods for caring for or treating the skin or hair, wherein the skin or hair is brought into contact with a composition according to the invention.
The invention will be explained in greater detail by the following examples:
Preparation Examples P1 to P3, Example 1 and Comparative Examples 1 to 4.
The N-acyl-N-methyl-glucamines described in the following were prepared according to EP 0 550 637 from the corresponding fatty acid methyl esters or triglycerides and N-methylglucamine in the presence of 1,2-propylene glycol as solvent and were obtained in the form of a solid consisting of active substance and 1,2-propylene glycol. The material obtained in Preparation Examples P1 to P3 comprises the indicated amount of 1,2-propylene glycol and is used directly in the examples shown in Table 2 without being purified further.
C12/14 means that the methyl ester consists of a mixture of lauric acid methyl ester (C12-acyl radical) and myristic acid methyl ester (C14-acyl radical) (ratio 75:25). C8/C18 means that the methyl ester consists of a natural distribution of the fatty acids in coconut oil (octanoic acid methyl ester, decanoic acid methyl ester, lauric acid methyl ester and myristic acid methyl ester, palmitic acid methyl ester, stearic acid methyl ester, oleic acid methyl ester, ratio approximately: 4:7:48:20:10:3:8).
Surfactant solutions consisting of sodium lauryl ether sulfate (Genapol LRO liq., Clariant), cocamidopropyl betaine (Genagen CAB 818, Clariant) and sugar-based surfactants were prepared according to Table 2 below and adjusted to a uniform viscosity of 5000 mPas by addition of sodium chloride. The total surfactant content was in each case 12%.
The products were evaluated by a trained sensory panel with 10 participants in respect of the parameters foam quality, foam creaminess, foaming behavior and amount of foam.
In the evaluation: ++=very good, +=good, o=satisfactory, −=adequate, −−=unsatisfactory, the parameters being evaluated qualitatively against the standard (Comparative Example 4) after determination of the mean.
As is clear from the results obtained, the use of N-acyl-N-methylglucamines based on C8/18 triglycerides according to Example 1 (e.g. based on coconut oil) leads, in comparison with a corresponding lauroyl derivative (Comparative Example 1) and a coconut derivative based on methyl ester, to an improved sensory evaluation of the foam behavior of the formulation as compared with the prior art.
Number | Date | Country | Kind |
---|---|---|---|
10 2012 010 655 | May 2012 | DE | national |
Filing Document | Filing Date | Country | Kind |
---|---|---|---|
PCT/EP2013/061065 | 5/29/2013 | WO | 00 |
Publishing Document | Publishing Date | Country | Kind |
---|---|---|---|
WO2013/178679 | 12/5/2013 | WO | A |
Number | Name | Date | Kind |
---|---|---|---|
2016962 | Flint | Oct 1935 | A |
2667478 | Schwartz | Jan 1954 | A |
2703798 | Schwartz | Mar 1955 | A |
2891052 | Boettner | Jun 1959 | A |
2982737 | Boettner | May 1961 | A |
2993887 | Zech | Jul 1961 | A |
4079078 | Collins | Mar 1978 | A |
4400196 | Albrecht | Aug 1983 | A |
4413087 | Bernot | Nov 1983 | A |
4481186 | Deckner | Nov 1984 | A |
4505827 | Rose | Mar 1985 | A |
4565647 | Llenado | Jan 1986 | A |
4654207 | Preston | Mar 1987 | A |
4681946 | Baur | Jul 1987 | A |
4981684 | MacKenzie | Jan 1991 | A |
5009814 | Kelkenberg | Apr 1991 | A |
5194639 | Connor | Mar 1993 | A |
5254281 | Pichardo | Oct 1993 | A |
5298195 | Brumbaugh | Mar 1994 | A |
5317047 | Sabate | May 1994 | A |
5354425 | Mackey | Oct 1994 | A |
5449770 | Shumate | Sep 1995 | A |
5454982 | Murch | Oct 1995 | A |
5500155 | Weuthen | Mar 1996 | A |
5539134 | Strecker | Jul 1996 | A |
5559078 | Garst | Sep 1996 | A |
5560873 | Chen | Oct 1996 | A |
5625098 | Kao | Apr 1997 | A |
5691299 | Fabry | Nov 1997 | A |
5711899 | Kawa | Jan 1998 | A |
5712235 | Nieendick | Jan 1998 | A |
5716922 | Curry | Feb 1998 | A |
5750748 | Boutique | May 1998 | A |
5766267 | Schumacher | Jun 1998 | A |
5777165 | Kao | Jul 1998 | A |
5789372 | Fabry | Aug 1998 | A |
5874096 | Hazen | Feb 1999 | A |
5945389 | Richard | Aug 1999 | A |
6147045 | Lappas | Nov 2000 | A |
6147124 | Ansmann | Nov 2000 | A |
6165955 | Chen | Dec 2000 | A |
6264961 | Ansmann | Jul 2001 | B1 |
6274126 | Newell | Aug 2001 | B1 |
6288023 | Honda | Sep 2001 | B1 |
6329331 | Aronson | Dec 2001 | B1 |
6350788 | Herold | Feb 2002 | B1 |
6391962 | Zerrer | May 2002 | B2 |
6455001 | Knappe | Sep 2002 | B1 |
6635708 | Papenfuhs | Oct 2003 | B1 |
6727217 | Nieendick | Apr 2004 | B1 |
6887838 | Dykstra | May 2005 | B2 |
6903057 | Tsaur | Jun 2005 | B1 |
7056379 | Nieendick | Jun 2006 | B2 |
7217752 | Schmucker-Castner | May 2007 | B2 |
7250392 | Leonard | Jul 2007 | B1 |
7297666 | Kuepper | Nov 2007 | B2 |
7407667 | Zerrer | Aug 2008 | B2 |
7578995 | Frantz | Aug 2009 | B2 |
7776318 | Bissey-Beugras | Aug 2010 | B2 |
7820771 | Lapra | Oct 2010 | B2 |
7872036 | Toriyabe | Jan 2011 | B2 |
7897543 | Bretschneider | Mar 2011 | B2 |
8084452 | Jeschke | Dec 2011 | B2 |
8178481 | Sans | May 2012 | B2 |
8263538 | Tsaur | Sep 2012 | B2 |
8324390 | Fischer | Dec 2012 | B2 |
8404855 | Jeschke | Mar 2013 | B2 |
8536340 | Hamamoto | Sep 2013 | B2 |
8637432 | Baur | Jan 2014 | B2 |
8729323 | Kothandaraman | May 2014 | B2 |
8759255 | Wacker | Jun 2014 | B2 |
8809547 | Bretschneider | Aug 2014 | B2 |
8901041 | Frisch | Dec 2014 | B2 |
9187407 | Koshti | Nov 2015 | B2 |
9504636 | Klug | Nov 2016 | B2 |
9949909 | Klug | Apr 2018 | B2 |
1017277 | Klug | Jan 2019 | A1 |
1026525 | Klug | Apr 2019 | A1 |
20010023298 | Weinelt | Sep 2001 | A1 |
20010056048 | Bertolosso | Dec 2001 | A1 |
20020004476 | Pancheri | Jan 2002 | A1 |
20020040662 | Dietz | Apr 2002 | A1 |
20020065198 | Highsmith | May 2002 | A1 |
20020168417 | Blease | Nov 2002 | A1 |
20030004929 | Julian | Jan 2003 | A1 |
20030049292 | Turowski-Wanke | Mar 2003 | A1 |
20030069153 | Jordan | Apr 2003 | A1 |
20030199403 | Wells | Oct 2003 | A1 |
20040086470 | Nieendick | May 2004 | A1 |
20050037926 | Zerrer | Feb 2005 | A1 |
20050037942 | Otterson | Feb 2005 | A1 |
20050172859 | Nieendick | Aug 2005 | A1 |
20050233935 | Gunn | Oct 2005 | A1 |
20060058205 | Ainger | Mar 2006 | A1 |
20060079414 | Nieendick | Apr 2006 | A1 |
20060089294 | Depoot | Apr 2006 | A1 |
20060100127 | Meier | May 2006 | A1 |
20060110415 | Gupta | May 2006 | A1 |
20060110432 | Luu | May 2006 | A1 |
20060135382 | Molenda | Jun 2006 | A1 |
20060142291 | Beilfuss | Jun 2006 | A1 |
20060166826 | Zerrer | Jul 2006 | A1 |
20060171979 | Calvo | Aug 2006 | A1 |
20070054820 | Harichian | Mar 2007 | A1 |
20070060489 | Sun | Mar 2007 | A1 |
20070110700 | Wells | May 2007 | A1 |
20070128144 | Bonastre Gilabert | Jun 2007 | A1 |
20070190004 | Bockmuhl | Aug 2007 | A1 |
20070213226 | Sieverding | Sep 2007 | A1 |
20080057014 | Masuda | Mar 2008 | A1 |
20080317960 | Pitt | Dec 2008 | A1 |
20090023622 | Leidreiter | Jan 2009 | A1 |
20090111847 | Li | Apr 2009 | A1 |
20090118152 | Lam | May 2009 | A1 |
20090124498 | Von Deyn | May 2009 | A1 |
20090253612 | Mushock | Oct 2009 | A1 |
20090257972 | Dieker | Oct 2009 | A1 |
20100051200 | Mueller | Mar 2010 | A1 |
20100285077 | Lintner | Nov 2010 | A1 |
20100326320 | Swedo | Dec 2010 | A1 |
20110002865 | Fournial | Jan 2011 | A1 |
20110146536 | Tomlinson | Jun 2011 | A1 |
20110150786 | Desenne | Jun 2011 | A1 |
20110152150 | Bernard | Jun 2011 | A1 |
20110177945 | Klingelhoefer | Jul 2011 | A1 |
20110251116 | Aehle | Oct 2011 | A1 |
20110263471 | Barnhart | Oct 2011 | A1 |
20120009127 | Dasgupta | Jan 2012 | A1 |
20120010113 | Hee | Jan 2012 | A1 |
20120070388 | Man | Mar 2012 | A1 |
20120094890 | Anantaneni | Apr 2012 | A1 |
20120172223 | Wacker | Jul 2012 | A1 |
20120244092 | Moser | Sep 2012 | A1 |
20130030197 | Harichian | Jan 2013 | A1 |
20130189212 | Jawale | Jul 2013 | A1 |
20130216491 | Ogihara | Aug 2013 | A1 |
20140135245 | Annaheim | May 2014 | A1 |
20140230841 | Mathonneau | Aug 2014 | A1 |
20140255330 | Cron | Sep 2014 | A1 |
20140303389 | Crosby | Oct 2014 | A1 |
20150032003 | Cho | Jan 2015 | A1 |
20150125415 | Klug et al. | May 2015 | A1 |
20150126424 | Klug et al. | May 2015 | A1 |
20150126616 | Klug et al. | May 2015 | A1 |
20150133560 | Klug et al. | May 2015 | A1 |
20150140048 | Klug et al. | May 2015 | A1 |
20150141466 | Klug et al. | May 2015 | A1 |
20150141508 | Klug et al. | May 2015 | A1 |
20150150767 | Klug et al. | Jun 2015 | A1 |
20150164755 | Klug et al. | Jun 2015 | A1 |
20150164756 | Klug et al. | Jun 2015 | A1 |
20150282478 | Baur | Oct 2015 | A1 |
20150320037 | Wacker | Nov 2015 | A1 |
20150335550 | Koshti | Nov 2015 | A1 |
20160074310 | Klug et al. | Mar 2016 | A1 |
20160136072 | Klug et al. | May 2016 | A1 |
20160143828 | Klug et al. | May 2016 | A1 |
20160243014 | Dahms et al. | Aug 2016 | A1 |
20160272666 | Klug et al. | Sep 2016 | A1 |
20160361243 | Klug et al. | Dec 2016 | A1 |
20170000710 | Klug et al. | Jan 2017 | A1 |
20170002297 | Klug et al. | Jan 2017 | A1 |
20170044434 | Baur et al. | Feb 2017 | A1 |
20170055524 | Baur et al. | Mar 2017 | A1 |
20170071199 | Baur et al. | Mar 2017 | A1 |
20170101606 | Klug et al. | Apr 2017 | A1 |
20170218293 | Klug et al. | Aug 2017 | A1 |
20170226349 | Kupfer | Aug 2017 | A1 |
20170265477 | Baur et al. | Sep 2017 | A1 |
20170292062 | Wylde et al. | Oct 2017 | A1 |
20170305838 | Appel et al. | Oct 2017 | A1 |
20180215879 | Kupfer | Aug 2018 | A1 |
20190076344 | Klug | Mar 2019 | A1 |
Number | Date | Country |
---|---|---|
2117007 | Sep 1994 | CA |
1333226 | Nov 1994 | CA |
2127644 | Jan 1995 | CA |
1061960 | Jun 1992 | CN |
1077489 | Oct 1993 | CN |
1078746 | Nov 1993 | CN |
1088258 | Jun 1994 | CN |
1140987 | Jan 1997 | CN |
1141653 | Jan 1997 | CN |
1155239 | Jul 1997 | CN |
1292641 | Apr 2001 | CN |
1296524 | May 2001 | CN |
1501772 | Jun 2004 | CN |
1518408 | Aug 2004 | CN |
1594518 | Mar 2005 | CN |
100528887 | May 2006 | CN |
1997341 | Jul 2007 | CN |
102186340 | Sep 2011 | CN |
102595882 | Jul 2012 | CN |
103468362 | Dec 2013 | CN |
103468382 | Dec 2013 | CN |
104918490 | Sep 2015 | CN |
1956509 | May 1971 | DE |
2226872 | Dec 1973 | DE |
4238211 | Jan 1994 | DE |
4235783 | Apr 1994 | DE |
4435383 | Nov 1995 | DE |
19507531 | Sep 1996 | DE |
19701127 | Jul 1998 | DE |
19808824 | Oct 1999 | DE |
19846429 | Apr 2000 | DE |
19916090 | Oct 2000 | DE |
10117993 | Oct 2002 | DE |
10130357 | Jan 2003 | DE |
102007034438 | Jan 2009 | DE |
202013011412 | Jan 2014 | DE |
202013011413 | Jan 2014 | DE |
102012021647 | May 2014 | DE |
0039860 | Nov 1981 | EP |
0048436 | Mar 1982 | EP |
0285768 | Oct 1988 | EP |
0285786 | Oct 1988 | EP |
0336151 | Oct 1989 | EP |
0378985 | Jul 1990 | EP |
0407874 | Jan 1991 | EP |
0539588 | May 1993 | EP |
0 550 637 | Jul 1993 | EP |
0572723 | Dec 1993 | EP |
0614881 | Sep 1994 | EP |
0633244 | Jan 1995 | EP |
0709449 | May 1996 | EP |
0745719 | Dec 1996 | EP |
0769548 | Apr 1997 | EP |
0774503 | May 1997 | EP |
0995994 | Apr 2000 | EP |
1043017 | Oct 2000 | EP |
1 078 978 | Feb 2001 | EP |
1093722 | Apr 2001 | EP |
1110944 | Jun 2001 | EP |
1177223 | Feb 2002 | EP |
1379129 | Jan 2004 | EP |
1422288 | May 2004 | EP |
1529832 | May 2005 | EP |
1676831 | Jul 2006 | EP |
1716842 | Nov 2006 | EP |
S4810053 | Feb 1973 | JP |
S63270534 | Nov 1988 | JP |
H06501731 | Feb 1994 | JP |
H06501733 | Feb 1994 | JP |
H06240599 | Aug 1994 | JP |
H07507341 | Aug 1995 | JP |
H0812993 | Jan 1996 | JP |
H0848618 | Feb 1996 | JP |
H09502476 | Mar 1997 | JP |
H09506683 | Jun 1997 | JP |
H09510956 | Nov 1997 | JP |
H10501279 | Feb 1998 | JP |
H10508043 | Aug 1998 | JP |
H11505839 | May 1999 | JP |
H11246890 | Sep 1999 | JP |
H11512334 | Oct 1999 | JP |
2000512286 | Sep 2000 | JP |
2000297028 | Oct 2000 | JP |
2001501635 | Feb 2001 | JP |
2001131579 | May 2001 | JP |
2001247528 | Sep 2001 | JP |
2002542344 | Dec 2002 | JP |
2006183030 | Jul 2006 | JP |
2006183039 | Jul 2006 | JP |
2007538023 | Dec 2007 | JP |
2008110953 | May 2008 | JP |
2010018586 | Jan 2010 | JP |
2010037252 | Feb 2010 | JP |
2013534232 | Sep 2013 | JP |
2014532815 | Dec 2014 | JP |
2015518026 | Jun 2015 | JP |
2017526776 | Sep 2017 | JP |
9205764 | Apr 1992 | WO |
9206073 | Apr 1992 | WO |
9206154 | Apr 1992 | WO |
9206162 | Apr 1992 | WO |
WO 9206158 | Apr 1992 | WO |
WO9206161 | Apr 1992 | WO |
WO 9206161 | Apr 1992 | WO |
WO-9206161 | Apr 1992 | WO |
9318125 | Sep 1993 | WO |
9319149 | Sep 1993 | WO |
9410130 | May 1994 | WO |
9412608 | Jun 1994 | WO |
9412609 | Jun 1994 | WO |
9419941 | Sep 1994 | WO |
9516824 | Jun 1995 | WO |
9517880 | Jul 1995 | WO |
9519415 | Jul 1995 | WO |
9523840 | Sep 1995 | WO |
9533033 | Dec 1995 | WO |
9533035 | Dec 1995 | WO |
WO 9603974 | Feb 1996 | WO |
9610386 | Apr 1996 | WO |
9614374 | May 1996 | WO |
9616540 | Jun 1996 | WO |
9628023 | Sep 1996 | WO |
9637589 | Nov 1996 | WO |
9637592 | Nov 1996 | WO |
9747284 | Dec 1997 | WO |
9800496 | Jan 1998 | WO |
9841601 | Sep 1998 | WO |
WO 9856496 | Dec 1998 | WO |
9951716 | Oct 1999 | WO |
0065014 | Nov 2000 | WO |
0137658 | May 2001 | WO |
0160877 | Aug 2001 | WO |
02089575 | Nov 2002 | WO |
2002096882 | Dec 2002 | WO |
03000055 | Jan 2003 | WO |
2003106457 | Dec 2003 | WO |
2004056358 | Jul 2004 | WO |
2004099150 | Nov 2004 | WO |
2004099160 | Nov 2004 | WO |
2005035486 | Apr 2005 | WO |
2005063094 | Jul 2005 | WO |
2005077934 | Aug 2005 | WO |
2005117580 | Dec 2005 | WO |
2006043635 | Apr 2006 | WO |
2006056433 | Jun 2006 | WO |
2006089633 | Aug 2006 | WO |
2006100288 | Sep 2006 | WO |
2007040280 | Apr 2007 | WO |
2007057407 | May 2007 | WO |
2007075459 | Jul 2007 | WO |
2007101369 | Sep 2007 | WO |
2007115643 | Oct 2007 | WO |
2007115644 | Oct 2007 | WO |
2007115646 | Oct 2007 | WO |
2007147500 | Dec 2007 | WO |
2007149134 | Dec 2007 | WO |
WO-2007141066 | Dec 2007 | WO |
2005085216 | Jan 2008 | WO |
2008009360 | Jan 2008 | WO |
2008066153 | Jun 2008 | WO |
2008067911 | Jun 2008 | WO |
2008104503 | Sep 2008 | WO |
2009002956 | Dec 2008 | WO |
2009029561 | Mar 2009 | WO |
2009049851 | Apr 2009 | WO |
2010005692 | Jan 2010 | WO |
2010006713 | Jan 2010 | WO |
2010069502 | Jun 2010 | WO |
2010074747 | Jul 2010 | WO |
2010074751 | Jul 2010 | WO |
2010126657 | Nov 2010 | WO |
2010138661 | Dec 2010 | WO |
2011138450 | Nov 2011 | WO |
2012061991 | May 2012 | WO |
2012116939 | Sep 2012 | WO |
2013016270 | Jan 2013 | WO |
2013178668 | Dec 2013 | WO |
2013178670 | Dec 2013 | WO |
2013178671 | Dec 2013 | WO |
2013178679 | Dec 2013 | WO |
2013178697 | Dec 2013 | WO |
2013178700 | Dec 2013 | WO |
2013178701 | Dec 2013 | WO |
2014056561 | Apr 2014 | WO |
2014067663 | May 2014 | WO |
2014170025 | Oct 2014 | WO |
2015082062 | Jun 2015 | WO |
2015124302 | Aug 2015 | WO |
2016023693 | Feb 2016 | WO |
2016041823 | Mar 2016 | WO |
Entry |
---|
The Chemistry of Coconut Oil, accessed online Jul. 12, 2018 (Year: 2018). |
U.S. Appl. No. 14/401,315, now published as US 2015-0133560. |
U.S. Appl. No. 14/401,323, now published as US 2015-0141508. |
U.S. Appl. No. 14/401,337, now published as US 2015-0141466. |
U.S. Appl. No. 14/401,789, now published as US 2015-0126616. |
U.S. Appl. No. 14/402,954, now published as US 2015-0140048. |
U.S. Appl. No. 14/899,835, now published as US 2016-0143828. |
U.S. Appl. No. 14/402,996, now published as US 2015-0164755. |
U.S. Appl. No. 14/403,049, now published as US 2015-0150767. |
U.S. Appl. No. 14/403,072, now published as US 2015-0164756. |
U.S. Appl. No. 14/401,796, now published as US 2015-0126424. |
U.S. Appl. No. 14/439,052, now published as US 2015-0320037. |
U.S. Appl. No. 14/785,599, now published as US 2016-0074310. |
U.S. Appl. No. 14/901,090, now published as US 2016-0136072. |
U.S. Appl. No. 15/037,172, now published as US 2016-0272666. |
U.S. Appl. No. 15/100,165, now published as US 2017-0002297. |
U.S. Appl. No. 15/039,970, now published as US 2016-0361243. |
U.S. Appl. No. 15/100,039, now published as US 2017-0000710. |
U.S. Appl. No. 15/035,120, now published as US 2016-0243014. |
U.S. Appl. No. 15/526,464, now published as US 2017-0305838. |
U.S. Appl. No. 15/120,097, now published as US 2017-0071199. |
U.S. Appl. No. 15/120,103, now published as US 2017-0055524. |
U.S. Appl. No. 15/123,065, now published as US 2017-0101606. |
U.S. Appl. No. 15/123,143, now published as US 2017-0218293. |
U.S. Appl. No. 15/307,205, now published as US 2017-0044434. |
U.S. Appl. No. 15/515,324, now published as US 2017-0265477. |
U.S. Appl. No. 15/511,987, now published as US 2017-0292062. |
U.S. Appl. No. 14/662,564. |
U.S. Appl. No. 14/677,500. |
U.S. Appl. No. 14/491,615. |
U.S. Appl. No. 15/562,852. |
U.S. Appl. No. 15/744,645. |
English Abstract for DE 4435383, Nov. 9, 1995. |
English Abstract for DE 19507531, Sep. 12, 1996. |
International Search Report for PCT/EP2013/061100, dated Jul. 16, 2014. |
Bezard (Lipids 1971;6:630-634). |
Dale et al. (J. Sci. Food. Agric. 1955;6:166-170) (Year: 1955). |
English Translation of Cited Excerpts of CN103468382A, Dec. 25, 2013. 2 pages. |
Friedrich Vogel: “Kosmetik aus der Sicht des Chemikers”, Chemie in Unserer Zeit, No. 5, Jan. 1, 1986, pp. 156-164, XP055109030, DOI: 10.1002/ciuz.19860200504 p. 160. |
Hardcopy of http://igf-bingen.de/Croda_produkte.pdf, Dec. 1, 2016. 3 pages. |
International Preliminary Report on Patentability for PCT/EP2013/061044, dated Feb. 12, 2014. 7 pages. |
International Preliminary Report on Patentability for PCT/EP2014/001723, dated Jun. 8, 2015. 16 pages. |
International Preliminary Report on Patentability for PCT/EP2015/000443, dated Jan. 22, 2016. 6 pages. |
International Preliminary Report on Patentability for PCT/EP2015/076072, dated May 16, 2017. 5 pages. |
International Search Report for PCT/EP2013/061044, dated May 15, 2014. 2 pages. |
International Search Report for PCT/EP2013/061047, dated May 22, 2014. 3 pages. |
International Search Report for PCT/EP2013/061075, dated May 15, 2014. 2 pages. |
International Search Report for PCT/EP2013/061076, mail date May 15, 2014.2 pages. |
International Search Report for PCT/EP2013/061100, dated Jul. 15, 2014. 4 pages. |
International Search Report for PCT/EP2014/001723, dated Jan. 5, 2015. 3 pages. |
International Search Report for PCT/EP2015/000443, dated Jun. 2, 2015.2 pages. |
International Search Report for PCT/EP2015/000871 dated Jul. 15, 2015. 3 pages. |
International Search Report for PCT/EP2015/076072, dated Feb. 29, 2016. 2 pages. |
Palm fatty acid distillate (PFAD) [online] retrieved on May 21, 2018 from: https://www.neste.com/ corporate-info/sustainability/sustainable-supply-chain/pfad-residue-palm-oil-refining-process; 1 page. (Year: 2018). |
Plante et al. Castor Oil [online] retrieved on 1/13/16 from: http://www.dionex.com/en-us/ webdocs/110518-Po-UHPLC-Castor-Oil-31May2011-LPN2822-01.pdf; 5 pages. |
PubChem, Methylmeglumine, 2006. (Year: 2006) 9 pages. |
Quack, et al., Fette-Seifen-Anstrichmittel 78, 200(1976). 7 pages. |
R. Mohammadi, J. Wassink, a. Amirfazli, “Effect of Surfactants on Wetting of Super-Hydrophobic Surfaces”, Langmuir, American Chemical Society, (20041001), vol. 20, No. 22, doi:10.1021/ la049268k, ISSN 07437463, pp. 9657-9662, XP055098502. |
Smith, J.T. et al., “Micellar Electrokinetic Capillary Chromatography with in Situ Charged Micelles. 1. Evaluation of N-D-Gluco-N-methylalkanamide Surfactants as Anionic Borate Complexes,” Anal. Chem. 1994, 66, 1119-1133. |
Söderlind, E. et al., “The usefulness of sugar surfactants as solubilizing agents in parenteral formulations,” Elsevier, I nternational !IJournal of Pharmaceutics 252 (2003) pp. 61-71, Aug. 19, 2002. |
Study on Synthesis and Properties of “Green” Surfactants—Glucamine derivates, Zhao Handong, Master Thesis, Southern Yangtze University, pp. 5-6, Jul. 25, 2007. |
Tan et al. (Appl Microbiol Biotechnol. 47:207-211) (Year: 1997). |
Tegeler, T. et al., Special Guest Editor Section: Electrically Driven Microseparation Methods for Pesticides and Metabolites: I. Micellar Electrokinetic Capillary Chromatography of Carbamate Insecticides with Mega-Borate and SDS Surfactants,″ Journal of AOAC International, vol. 82, No. 6, pp. 1542-1549, Nov. 6, 1999. |
V. Bergeron, P. Cooper, C. Fischer. J. Giermanska-Kahn, D. Langevin, and a. Pouchelon, “Polydimethylsiloxane (PDMS)-based antifoams” Colloids and Surfaces A: Physicochemical and Engineering Aspects 122 (1997) 103 120. 18 pages. |
Walter, a. ; Suchy, S.E. ; Vinson, P.K., “Solubility properties of the alkylmethylglucamide surfactants”, Biochimica et Biophysica Acta (BBA)-Biomembranes, Elsevier, Amsterdam, NL, Amsterdam, NL, (19901102), vol. 1029, No. 1, doi:10.1016/0005-2736(90)90437-S, ISSN 0005-2736, pp. 67-74, XP023354648. |
Zhu, Y-P, et al., “Surface Properties of N-Alkanoyl-N-Methy Glucamines and Related Materials”, J. Of Surfactants and Detergents, vol. 2, No. 3, Jul. 1, 1999.6 pages. |
Lichtenthaler, F.W., “Carbohydrates as Organic Raw Materials,” in Ullmann's Encyclopedia of Industrial Chemistry, Wiley-VCH Verlag, 2010. (34 pages). |
“Product Specification: N-octanoyl-N-methylglucamine”, Jun. 29, 2000 (Jun. 29, 2000), pp. 1-1, XP055098500, Retrieved from the Internet: Url:http://www.sigmaaldrich.com/Graphics/COfAlnfo/ SigmaSAPQM/Spec/03/03129/03129 -BULKSIGMA.pdf. |
European Coatings Journal in 2009, vol. 07, pp. 26-28. |
International Preliminary Report on Patentability for PCT/EP2016/071750, dated Apr. 10, 2018, 5 pages. |
International Search Report for PCT/EP2013/003290, dated Feb. 10, 2014. 5 pages. |
International Search Report for PCT/EP2014/001722, dated Jan. 5, 2015. 3 pages. |
International Search Report for PCT/EP2015/072453, dated Oct. 23, 2015. 2 pages. |
International Search Report for PCT/EP2016/063433, dated Aug. 24, 2016. 2 pages. |
International Search Report for PCT/EP2016/071750, dated Jan. 28, 2017, 3 pages. |
International Search Report for PCT/EP2016/074085, dated Jan. 3, 2017, 3 pages. |
Synergen OS Innovation Spotlight, Sep. 1, 2013, 5 pages. |
Number | Date | Country | |
---|---|---|---|
20150125415 A1 | May 2015 | US |